TRY NOW

Enhance and accelerate your early stage research with trusted and comprehensive intelligence from Thomson Reuters.

Start your free trial in just two simple steps.

Get your FREE trial

Enrich your discovery science with market leading, manually curated scientific intelligence. Systems Biology, Preclinical, Biomarkers, Chemistry, Biology, and Pharmacology - and everything in between. Covered from the perspective that matters most – yours.
Customer Feedback
Customer Feedback

Annette Bakker, Chief Scientific Officer from CTF, explains the reasons why she likes to work with Thomson Reuters. Currently using MetaCore™ to identify disease treatment options.

Live & Recorded Training

Attend one of our regularly scheduled webinar training sessions for overviews of features, tools, and content – find the schedule here

Free Pathway Maps

Search or browse through a wide range of proprietary multi-step canonical pathway maps here.

Featured News

The latest news from Life Sciences Research
The future of COPD treatment

The future of COPD treatment

Our research shows greater focus on preventative therapies

Translational Medicine

Translational Medicine

Supplement-Size Doses of Antioxidants Hasten Lung Cancer Progression

Tet Proteins Erase Epigenetic Marks

Tet Proteins Erase Epigenetic Marks

It is (reasonably) common knowledge that DNA is written in a simple four-letter code: ACTG. Too simple, actually.

Blog Highlights

Read our latest blog posts

Video: Novavax Ready to Respond Fast to MERS, H7N9 Outbreaks

Stanley C. Erck, president and CEO, explained to BioWorld why Novavax Inc. stays tightly focused on vaccine development while other drug developers have backed away ...

Analyzing the Commercial Biosimilar Landscape

The 15th annual Business of Biosimilars conference was a continuation of many of the market discussions that have previously surrounded the biologics and biosimilars landscape. ...

New FDA Guidance Clarifies the Transfer of Clinical Research Projects to a New Institutional Review Board (IRB)

Code of Federal Regulations (CFR) Title 45 – Part 46: Protection of Human Subjects provides a regulatory basis for policies that protect individuals in investigative ...

Whitepapers & Publications

View our recent whitepapers and publications

BioMarker White Paper

White paper establishing the standards in biomarker research.

Thomson Reuters Professional Services White Paper

Knowledge-Based Drug Repositioning to Drive R&D Productivity

Thomson Reuters Professional Services Report

The economic power of orphan drugs

Latest on Twitter

Latest on Linked In